Elevated peripheral blood plasma concentrations of tie-2 and angiopoietin 2 in patients with neuroendocrine tumors

Int J Mol Sci. 2012;13(2):1444-1460. doi: 10.3390/ijms13021444. Epub 2012 Jan 31.

Abstract

Background: Gastro-entero-pancreatic/neuroendocrine (NET) tumors are highly vascularized neoplasms. However, our knowledge concerning circulating levels of the angiogenic factors in NET patients still remains insufficient.

Methods: The aim of this study was to measure plasma concentrations of VEGF, angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2), soluble Tie-2, endostatin, osteopontin (OPN) and chromogranin A (CgA) in 36 NET patients and 16 controls.

Results: Only the plasma concentrations of Tie-2 and CgA were higher in NET patients as compared to controls. These levels were within the reference range in controls; however one control demonstrated slightly elevated Tie-2 and 4 elevated CgA. Similarly, in the subgroup of patients with carcinoid syndrome, only Tie-2 and CgA concentrations were higher than those in patients with non-functioning NETs. In turn, in the subgroup of metastatic patients, only Ang-2 levels were higher than in those with localized disease. A positive correlation was found between Ang-2 and Tie-2 levels in metastatic patients and between Ang-1 and Tie-2 in localized NETs.

Conclusions: The plasma concentration of Tie-2 is proposed as an additional marker for NET patients and seems to be similarly effective as the currently used CgA level. Moreover, higher plasma levels of Ang-2 together with the positive correlation between Ang-2 and Tie-2 levels in metastatic subjects, implies that cases with a Tie-2 level above the upper limits, together with higher level of Ang-2 seem to be highly predictive of metastases.

Keywords: Ang-1; Ang-2; NET patients; Tie-2; angiogenic factors.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Angiopoietin-2 / blood*
  • Biomarkers, Tumor / blood*
  • Carcinoma, Neuroendocrine* / blood
  • Carcinoma, Neuroendocrine* / mortality
  • Chromogranin A / blood
  • Endostatins / blood
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Proteins / blood*
  • Osteopontin / blood
  • Receptor, TIE-2 / blood*

Substances

  • ANGPT2 protein, human
  • Angiopoietin-2
  • Biomarkers, Tumor
  • CHGA protein, human
  • Chromogranin A
  • Endostatins
  • Neoplasm Proteins
  • Osteopontin
  • Receptor, TIE-2